Ridgewood Investments’s Immunome IMNM Stock Holding History

Ridgewood Investments’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,013	Closed	-$159K	–	195
2022 Q1	$159K	Hold	28,013	–	–	0.1%	186
2021 Q4	$363K	Hold	28,013	–	–	0.23%	132
2021 Q3	$682K	Sell	28,013 -30,000	-52%	-$523K	0.46%	72
2021 Q2	$1M	Buy	+58,013	New	+$1.28M	0.64%	53

Other funds holding IMNM

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ridgewood Investments's IMNM Position: Q2 2022 in Review

Ridgewood Investments sold out of Immunome (IMNM) in Q2 2022, closing a stake of 28,013 shares — an estimated $159K sold.

Ridgewood Investments first reported a position in IMNM in Q2 2021 and held it in 4 quarters. The position peaked at $1M in Q2 2021. 26 funds tracked by Wall St. Rank hold IMNM as of Q2 2022.

Ridgewood Investments reported no remaining Immunome position as of Q2 2022 after selling out during the quarter.
Ridgewood Investments sold 28,013 Immunome shares in Q2 2022, an estimated $159K.
Ridgewood Investments first reported a position in Immunome in Q2 2021 and held it in 4 quarters.
Ridgewood Investments's Immunome position peaked at $1M in Q2 2021.
26 funds tracked by Wall St. Rank held Immunome as of Q2 2022.

Based on Ridgewood Investments's 13F filing for Q2 2022, filed 19 Jul 2022.